Fisher B, Anderson S, Bryant J, Margolese RG, Deutsch M, Fisher ER, Jeong JH, Wolmark N (2002) Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 347(16):1233–1241
2.Veronesi U, Cascinelli N, Mariani L, Greco M, Saccozzi R, Luini A, Aguilar M, Marubini E (2002) Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med 347(16):1227–1232
3.Hofvind S, Holen A, Aas T, Roman M, Sebuodegard S, Akslen LA (2015) Women treated with breast conserving surgery do better than those with mastectomy independent of detection mode, prognostic and predictive tumor characteristics. European J Surg Oncol 41(10):1417–1422
4.Hwang ES, Lichtensztajn DY, Gomez SL, Fowble B, Clarke CA (2013) Survival after lumpectomy and mastectomy for early stage invasive breast cancer: the effect of age and hormone receptor status. Cancer 119(7):1402–1411
5.Hennigs A, Hartmann B, Rauch G, Golatta M, Tabatabai P, Domschke C, Schott S, Schutz F, Sohn C, Heil J (2015) Long-term objective esthetic outcome after breast-conserving therapy. Breast Cancer Res Treat 153(2):345–351
6.Foersterling E, Golatta M, Hennigs A, Schulz S, Rauch G, Schott S, Domschke C, Schuetz F, Sohn C, Heil J (2014) Predictors of early poor aesthetic outcome after breast-conserving surgery in patients with breast cancer: initial results of a prospective cohort study at a single institution. J Surg Oncol 110(7):801–806
7.Volders JH, Negenborn VL, Haloua MH, Krekel NMA, Jozwiak K, Meijer S, van den Tol PM (2018) Breast-specific factors determine cosmetic outcome and patient satisfaction after breast-conserving therapy: Results from the randomized COBALT study. J Surg Oncol 117(5):1001–1008
8.Heil J, Holl S, Golatta M, Rauch G, Rom J, Marme F, Gebauer G, Sohn C (2010) Aesthetic and functional results after breast conserving surgery as correlates of quality of life measured by a German version of the Breast Cancer Treatment Outcome Scale (BCTOS). Breast 19(6):470–474
9.Waljee JF, Hu ES, Ubel PA, Smith DM, Newman LA, Alderman AK (2008) Effect of esthetic outcome after breast-conserving surgery on psychosocial functioning and quality of life. J Clin Oncol 26(20):3331–3337
10.Horst KC, Smitt MC, Goffinet DR, Carlson RW (2005) Predictors of local recurrence after breast-conservation therapy. Clin Breast Cancer 5(6):425–438
11.Funk A, Heil J, Harcos A, Gomez C, Stieber A, Junkermann H, Hennigs A, Rauch G, Sinn HP, Riedel F et al (2020) Efficacy of intraoperative specimen radiography as margin assessment tool in breast conserving surgery. Breast Cancer Res Treat 179(2):425–433
12.Ciccarelli G, Di Virgilio MR, Menna S, Garretti L, Ala A, Giani R, Bussone R, Canavese G, Berardengo E (2007) Radiography of the surgical specimen in early stage breast lesions: diagnostic reliability in the analysis of the resection margins. Radiol Med 112(3):366–376
13.Chagpar AB, Butler M, Killelea BK, Horowitz NR, Stavris K, Lannin DR (2015) Does three-dimensional intraoperative specimen imaging reduce the need for re-excision in breast cancer patients? A prospective cohort study. Am J Surg 210(5):886–890
14.von Minckwitz G, Untch M, Blohmer JU, Costa SD, Eidtmann H, Fasching PA, Gerber B, Eiermann W, Hilfrich J, Huober J et al (2012) Definition and impact of pathologic complete response on prognosis after neoadjuvant chemotherapy in various intrinsic breast cancer subtypes. J Clin Oncol 30(15):1796–1804
15.Heil J, Kuerer HM, Pfob A, Rauch G, Sinn HP, Golatta M, Liefers GJ, Vrancken Peeters MJ (2020) Eliminating the breast cancer surgery paradigm after neoadjuvant systemic therapy: current evidence and future challenges. Ann Oncol 31(1):61–71
16.Interdisziplinäre S3-Leitlinie für die Diagnostik, Therapie und Nachsorge des Mammakarzinoms [http://www.awmf.org/uploads/tx_szleitlinien/032-045OL_k_S3__Brustkrebs_Mammakarzinom_Diagnostik_Therapie_Nachsorge_2012-07.pdf].
17.Fachgesellschaften AdWM: Interdisziplinäre S3-Leitlinie für die Früherkennung, Diagnostik, Therapie und Nachsorge des Mammakarzinoms. 2017.
18.McCormick JT, Keleher AJ, Tikhomirov VB, Budway RJ, Caushaj PF (2004) Analysis of the use of specimen mammography in breast conservation therapy. Am J Surg 188(4):433–436
19.Hisada T, Sawaki M, Ishiguro J, Adachi Y, Kotani H, Yoshimura A, Hattori M, Yatabe Y, Iwata H (2016) Impact of intraoperative specimen mammography on margins in breast-conserving surgery. Mol Clin Oncol 5(3):269–272
20.Schmachtenberg C, Engelken F, Fischer T, Bick U, Poellinger A, Fallenberg EM (2012) Intraoperative specimen radiography in patients with nonpalpable malignant breast lesions. Rofo 184(7):635–642
21.Mazouni C, Rouzier R, Balleyguier C, Sideris L, Rochard F, Delaloge S, Marsiglia H, Mathieu MC, Spielman M, Garbay JR (2006) Specimen radiography as predictor of resection margin status in non-palpable breast lesions. Clin Radiol 61(9):789–796
22.Versteegden DPA, Keizer LGG, Schlooz-Vries MS, Duijm LEM, Wauters CAP, Strobbe LJA (2017) Performance characteristics of specimen radiography for margin assessment for ductal carcinoma in situ: a systematic review. Breast Cancer Res Treat 166:669–679
23.Rua C, Lebas P, Michenet P, Ouldamer L (2012) Evaluation of lumpectomy surgical specimen radiographs in subclinical, in situ and invasive breast cancer, and factors predicting positive margins. Diagn Interv Imaging 93(11):871–877
24.Laws A, Brar MS, Bouchard-Fortier A, Leong B, Quan ML (2018) Does intra-operative margin assessment improve margin status and re-excision rates? A population-based analysis of outcomes in breast-conserving surgery for ductal carcinoma in situ. J Surg Oncol 118(7):1205–1211
25.Laws A, Brar MS, Bouchard-Fortier A, Leong B, Quan ML (2016) Intraoperative margin assessment in wire-localized breast-conserving surgery for invasive cancer: a population-level comparison of techniques. Ann Surg Oncol 23(10):3290–3296
26.Gray RJ, Pockaj BA, Garvey E, Blair S (2017) Intraoperative margin management in breast-conserving surgery: a systematic review of the literature. Ann Surg Oncol 25:18–27
27.Green RT, Weiser R, Golan O, Menes TS (2021) In search of the lost clip: outcome of women after needle-guided lumpectomy of a marking clip. Ann Surg Oncol 28(9):4974–4980
28.Heil J, Pfob A (2020) Patients should be the tipping point of individualizing breast cancer surgery: Commentary on “Eliminating the breast cancer surgery paradigm after neoadjuvant systemic therapy: current evidence and future challenges.” Ann Oncol 31(9):1264
29.Dahlback C, Manjer J, Rehn M, Ringberg A (2016) Determinants for patient satisfaction regarding aesthetic outcome and skin sensitivity after breast-conserving surgery. World J Surg Oncol 14(1):303
30.Cochrane RA, Valasiadou P, Wilson AR, Al-Ghazal SK, Macmillan RD (2003) Cosmesis and satisfaction after breast-conserving surgery correlates with the percentage of breast volume excised. Br J Surg 90(12):1505–1509
31.Clingan R, Griffin M, Phillips J, Coberly W, Jennings W (2003) Potential margin distortion in breast tissue by specimen mammography. Arch Surg 138(12):1371–1374
32.Helvie MA, Joynt LK, Cody RL, Pierce LJ, Adler DD, Merajver SD (1996) Locally advanced breast carcinoma: accuracy of mammography versus clinical examination in the prediction of residual disease after chemotherapy. Radiology 198(2):327–332
33.Moskovic EC, Mansi JL, King DM, Murch CR, Smith IE (1993) Mammography in the assessment of response to medical treatment of large primary breast cancer. Clin Radiol 47(5):339–344
34.Goorts B, van Nijnatten TJ, de Munck L, Moossdorff M, Heuts EM, de Boer M, Lobbes MB, Smidt ML (2017) Clinical tumor stage is the most important predictor of pathological complete response rate after neoadjuvant chemotherapy in breast cancer patients. Breast Cancer Res Treat 163(1):83–91
35.Kagihara JA, Andress M, Diamond JR (2020) Nab-paclitaxel and atezolizumab for the treatment of PD-L1-positive, metastatic triple-negative breast cancer: review and future directions. Expert Rev Precis Med Drug Dev 5(2):59–65
36.Schaefgen B, Mati M, Sinn HP, Golatta M, Stieber A, Rauch G, Hennigs A, Richter H, Domschke C, Schuetz F et al (2016) Can routine imaging after neoadjuvant chemotherapy in breast cancer predict pathologic complete response? Ann Surg Oncol 23(3):789–795
37.Pfob A, Sidey-Gibbons C, Lee HB, Tasoulis MK, Koelbel V, Golatta M, Rauch GM, Smith BD, Valero V, Han W et al (2021) Identification of breast cancer patients with pathologic complete response in the breast after neoadjuvant systemic treatment by an intelligent vacuum-assisted biopsy. Eur J Cancer 143:134–146
38.Amer HA, Schmitzberger F, Ingold-Heppner B, Kussmaul J, El Tohamy MF, Tantawy HI, Hamm B, Makowski M, Fallenberg EM (2017) Digital breast tomosynthesis versus full-field digital mammography-Which modality provides more accurate prediction of margin status in specimen radiography? Eur J Radiol 93:258–264
39.Park KU, Kuerer HM, Rauch GM, Leung JWT, Sahin AA, Wei W, Li Y, Black DM (2019) Digital breast tomosynthesis for intraoperative margin assessment during breast-conserving surgery. Ann Surg Oncol 26(6):1720–1728
40.Molina MA, Snell S, Franceschi D, Jorda M, Gomez C, Moffat FL, Powell J, Avisar E (2009) Breast specimen orientation. Ann Surg Oncol 16(2):285–288
留言 (0)